These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 3088240)

  • 1. Renal handling of carnitine in children with carnitine deficiency and hyperammonemia associated with valproate therapy.
    Matsuda I; Ohtani Y; Ninomiya N
    J Pediatr; 1986 Jul; 109(1):131-4. PubMed ID: 3088240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ammonia and carnitine concentrations in children treated with sodium valproate compared with other anticonvulsant drugs.
    Thom H; Carter PE; Cole GF; Stevenson KL
    Dev Med Child Neurol; 1991 Sep; 33(9):795-802. PubMed ID: 1936631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status.
    Hamed SA; Abdella MM
    Epilepsy Res; 2009 Sep; 86(1):32-41. PubMed ID: 19446440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal handling of free and acylcarnitine in secondary carnitine deficiency.
    Ohtani Y; Nishiyama S; Matsuda I
    Neurology; 1984 Jul; 34(7):977-9. PubMed ID: 6539878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The problems of valproate therapy in severely handicapped children--valproate induced hyperammonemia and hypocarnitinemia].
    Matsui K; Iwamoto H; Ohtsuki N; Kobayashi T; Miyake S; Yamada M
    No To Hattatsu; 1991 Jan; 23(1):32-8. PubMed ID: 1825272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carnitine deficiency and hyperammonemia in children receiving valproic acid with and without other anticonvulsant drugs.
    Verrotti A; Greco R; Morgese G; Chiarelli F
    Int J Clin Lab Res; 1999; 29(1):36-40. PubMed ID: 10356662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carnitine disposition before and during valproate therapy in patients with epilepsy.
    Riva R; Albani F; Gobbi G; Santucci M; Baruzzi A
    Epilepsia; 1993; 34(1):184-7. PubMed ID: 8422857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum and urinary carnitine and organic acids in Reye syndrome and Reye-like syndrome.
    Sugimoto T; Nishida N; Woo M; Takeuchi T; Yasuhara A; Kobayashi Y; Sakane Y
    Brain Dev; 1986; 8(3):257-61. PubMed ID: 3766902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum and urine total, free and acylcarnitine levels related to age: assessment of renal handling of carnitine.
    Güneral F
    Turk J Pediatr; 1995; 37(3):217-22. PubMed ID: 7502358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carnitine Deficiency in Chinese Children with Epilepsy on Valproate Monotherapy.
    Qiliang L; Wenqi S; Hong J
    Indian Pediatr; 2018 Mar; 55(3):222-224. PubMed ID: 29629695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carnitine deficiency and hyperammonemia associated with valproic acid therapy.
    Ohtani Y; Endo F; Matsuda I
    J Pediatr; 1982 Nov; 101(5):782-5. PubMed ID: 6813444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carnitine status in Reye and Reye-like syndromes.
    Matsuda I; Ohtani Y
    Pediatr Neurol; 1986; 2(2):90-4. PubMed ID: 3508684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carnitine palmitoyltransferase 2 deficiency: the time-course of blood and urinary acylcarnitine levels during initial L-carnitine supplementation.
    Hori T; Fukao T; Kobayashi H; Teramoto T; Takayanagi M; Hasegawa Y; Yasuno T; Yamaguchi S; Kondo N
    Tohoku J Exp Med; 2010 Jul; 221(3):191-5. PubMed ID: 20543534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between the Serum Carnitine Level and Ammonia and Valproic Acid Levels in Patients with Bipolar Disorder.
    Yokoyama S; Yasui-Furukori N; Nakagami T; Miyazaki K; Ishioka M; Tarakita N; Kubo K; Sugawara N; Shimoda K
    Ther Drug Monit; 2020 Oct; 42(5):766-770. PubMed ID: 32482992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The decreased level of plasma carnitine in patients with epilepsy].
    Belousova ED
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(6):106-110. PubMed ID: 28745680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased serum carnitine in valproate induced Reye syndrome.
    Böhles H; Richter K; Wagner-Thiessen E; Schäfer H
    Eur J Pediatr; 1982 Nov; 139(3):185-6. PubMed ID: 6819143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproate-associated hyperammonemia and DL-carnitine supplement.
    Komatsu M; Kodama S; Yokoyama S; Konishi H; Tanaka K; Momota K; Wada H; Matsuo T
    Kobe J Med Sci; 1987 Jun; 33(3):81-7. PubMed ID: 2959815
    [No Abstract]   [Full Text] [Related]  

  • 18. Alteration of renal carnitine metabolism by anticonvulsant treatment.
    Camiña MF; Rozas I; Castro-Gago M; Paz JM; Alonso C; Rodriguez-Segade S
    Neurology; 1991 Sep; 41(9):1444-8. PubMed ID: 1891096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carnitine deficiency associated with anticonvulsant therapy.
    Rodriguez-Segade S; de la Peña CA; Tutor JC; Paz JM; Fernandez MP; Rozas I; Del Río R
    Clin Chim Acta; 1989 May; 181(2):175-81. PubMed ID: 2500272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium valproate-induced Fanconi syndrome in two severely disabled patients receiving carnitine supplementation.
    Ono H
    Clin Exp Nephrol; 2019 Jan; 23(1):148-149. PubMed ID: 29679355
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.